Barclays’s Gossamer Bio GOSS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $416K | Buy |
338,792
+93,692
| +38% | +$115K | ﹤0.01% | 3133 |
|
2025
Q1 | $270K | Buy |
245,100
+245,000
| +245,000% | +$270K | ﹤0.01% | 3180 |
|
2024
Q4 | $0 | Sell |
100
-20,964
| -100% | – | ﹤0.01% | 4405 |
|
2024
Q3 | $21K | Sell |
21,064
-748,564
| -97% | -$746K | ﹤0.01% | 4058 |
|
2024
Q2 | $693K | Buy |
769,628
+769,528
| +769,528% | +$693K | ﹤0.01% | 2322 |
|
2024
Q1 | $0 | Hold |
100
| – | – | ﹤0.01% | 4203 |
|
2023
Q4 | $0 | Sell |
100
-100
| -50% | – | ﹤0.01% | 4254 |
|
2023
Q3 | $0 | Buy |
200
+99
| +98% | – | ﹤0.01% | 4304 |
|
2023
Q2 | $0 | Sell |
101
-41,479
| -100% | – | ﹤0.01% | 4300 |
|
2023
Q1 | $52K | Sell |
41,580
-1,391,040
| -97% | -$1.74M | ﹤0.01% | 3777 |
|
2022
Q4 | $3.11M | Buy |
1,432,620
+1,279,971
| +839% | +$2.78M | ﹤0.01% | 1383 |
|
2022
Q3 | $1.83M | Buy |
152,649
+147,670
| +2,966% | +$1.77M | ﹤0.01% | 1717 |
|
2022
Q2 | $41K | Buy |
+4,979
| New | +$41K | ﹤0.01% | 3803 |
|
2022
Q1 | – | Sell |
-72,450
| Closed | -$819K | – | 4794 |
|
2021
Q4 | $819K | Buy |
+72,450
| New | +$819K | ﹤0.01% | 2306 |
|
2021
Q3 | – | Sell |
-13,429
| Closed | -$109K | – | 4017 |
|
2021
Q2 | $109K | Buy |
13,429
+12,942
| +2,657% | +$105K | ﹤0.01% | 3113 |
|
2021
Q1 | $5K | Sell |
487
-27,234
| -98% | -$280K | ﹤0.01% | 3755 |
|
2020
Q4 | $268K | Buy |
+27,721
| New | +$268K | ﹤0.01% | 2579 |
|
2020
Q3 | – | Sell |
-52,714
| Closed | -$685K | – | 3792 |
|
2020
Q2 | $685K | Buy |
52,714
+51,745
| +5,340% | +$672K | ﹤0.01% | 2144 |
|
2020
Q1 | $10K | Buy |
969
+960
| +10,667% | +$9.91K | ﹤0.01% | 3483 |
|
2019
Q4 | $0 | Sell |
9
-86,188
| -100% | – | ﹤0.01% | 3998 |
|
2019
Q3 | $1.45M | Buy |
+86,197
| New | +$1.45M | ﹤0.01% | 2016 |
|
2019
Q2 | – | Sell |
-3,138
| Closed | -$68K | – | 4294 |
|
2019
Q1 | $68K | Buy |
+3,138
| New | +$68K | ﹤0.01% | 3522 |
|